TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BBOT

BridgeBio Oncology Therapeutics, Inc.

Healthcare · Biotechnology

3.90$ -1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

BridgeBio Oncology Therapeutics, Inc. (BBOT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 377 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BBOT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
0.1 0.3 188 190 192 194 150 151 485 448 418 377
– – 2.1 2.1 2.0 1.9 141 142 476 425 267 242
– – 1.8 1.8 1.8 1.7 26 32 409 374 53 54
– – 1.8 1.8 1.8 1.7 136 131 468 425 252 226
– – – – – – 0.0 1.1 0.2 0.4 0.1 –
0.2 0.4 5.5 5.6 5.6 5.7 350 379 38 37 45 54
0.2 0.4 0.0 0.1 0.1 0.2 24 27 36 35 43 52
0.0 0.1 – – – – 0.0 0.3 0.5 0.5 0.5 0.6
– – – – – 3.1 3.7 2.2 3.7 1.4 12 6.7
0.0 -0.1 182 184 187 189 -200 -228 447 411 372 323
0.0 -0.1 -3.2 -3.4 -3.5 -3.7 -245 -273 -318 -357 -399 -455
20 20 24 24 24 0.0 0.4 0.1 43 80 0.1 0.1

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?